| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |